Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02293824 · ClinicalTrials.gov registry record
Effect of Feedings on Caffeine in Premature Infants
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 50
- Enrollment target
NCT02293824 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 50 participants.
The verdict
NCT02293824 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Almost all infants born \<29 weeks gestational age develop apnea of prematurity and are treated with caffeine. Type of diet and disease states may be significant contributors of variability in caffeine metabolism and pharmacokinetics (PK) in this population. This prospective, observational, open-label, opportunistic PK study will compare the population PK of caffeine between infants fed formula and infants fed exclusively breast milk; compare the activities of caffeine metabolizing enzymes between infants fed formula and infants fed exclusively breast milk; and determine the effect of hypoxia, hypotension, and infection on caffeine PK and metabolism in premature infants.
Interventions
- DRUG Caffeine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02293824
The ClinicalTrials.gov registry entry for NCT02293824 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Caffeine is the first listed.
NCT02293824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02293824 about?
NCT02293824 is a clinical study titled "Effect of Feedings on Caffeine in Premature Infants". Almost all infants born \<29 weeks gestational age develop apnea of prematurity and are treated with caffeine. Type of diet and disease states may be significant contributors of variability in caffeine metabolism and pharmacokinetics (PK) in this population. This prospective, observational, open-lab...
What is the current status of trial NCT02293824?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2014-12. Estimated completion is 2017-06-30.
What interventions are being tested in trial NCT02293824?
The interventions under investigation include: Caffeine (DRUG).
Who is sponsoring clinical trial NCT02293824?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.